UZH-Logo

Maintenance Infos

Browse by Communities & Collections - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items at this level: 315.

Published in final form

Noske, Aurelia; Brandt, Simone; Valtcheva, Nadejda; Wagner, Ulrich; Zhong, Qing; Bellini, Elisa; Fink, Daniel; Obermann, Ellen C; Moch, Holger; Wild, Peter J (2017). Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer. OncoTarget, 8(9):14794-14805.

Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; Töpfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.

Schumpf, Lea F; Theill, Nathan; Scheiner, David A; Fink, Daniel; Riese, Florian; Betschart, Cornelia (2017). Urinary incontinence and its association with functional physical and cognitive health among female nursing home residents in Switzerland. BMC Geriatrics, 17(1):17.

Brandt, Simone; Samartzis, Eleftherios P; Zimmermann, Anne-Kathrin; Fink, Daniel; Moch, Holger; Noske, Aurelia; Dedes, Konstantin J. (2017). Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer. BMC Cancer, 17:44.

Betschart, Cornelia; Cervigni, Mauro; Contreras Ortiz, Oscar; Doumouchtsis, Stergios K; Koyama, Masayasu; Medina, Carlos; Haddad, Jorge Milhem; la Torre, Filippo; Zanni, Giuliano (2017). Management of apical compartment prolapse (uterine and vault prolapse): A FIGO Working Group report. Neurourology and Urodynamics, 36(2):507-513.

Schraag, Sabrina M; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Schmidt, Ana-Maria (2017). Uterine tumors resembling ovarian sex cord tumors: treatment, recurrence, pregnancy and brief review. Gynecologic Oncology Reports, 19:53-56.

Matter-Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver; Swiss Group for Clinical Cancer Research (2016). A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing. Journal of Thoracic Oncology, 11(11):1846-1855.

Betschart, Cornelia; Ghisu, Gian-Piero; Fink, Daniel (2016). Normale und abnorme kolposkopische Befunde. Praxis, 105(23):1363-1369.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Author's reply to letter from Matthes and Zucca-Matthes on "Quantitative analyses of variability in normal vaginal shape and dimension on MR images". International Urogynecology Journal and Pelvic Floor Dysfunction, 27(10):1611.

Scheiner, David; Bracone, Gabriela; Imesch, Patrick; Fink, Daniel; Imthurn, Bruno (2016). Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue. Journal of Ovarian Research, 9(1):59.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Blut im Urin, was nun? Abklärung der nicht-sichtbaren Hämaturie bei der Frau. Praxis, 105(19):1133-1141.

Matter-Walstra, Klazien; Ruhstaller, T; Klingbiel, D; Schwenkglenks, Matthias; Dedes, K J (2016). Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK). Breast Cancer Research and Treatment, 158(1):51-57.

Luo, Jiajia; Betschart, Cornelia; Ashton-Miller, James A; DeLancey, John O L (2016). Quantitative analyses of variability in normal vaginal shape and dimension on MR images. International Urogynecology Journal and Pelvic Floor Dysfunction, 27(7):1087-1095.

Badir, S; Mazza, E; Bajka, M (2016). Objective assessment of cervical stiffness after administration of misoprostol for intrauterine contraceptive insertion. Ultrasound international open, 2(2):E63-E67.

Schmidt, Ana-Maria; Imesch, Patrick; Fink, Daniel; Egger, Herwig (2016). Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients. International Journal of Gynecological Cancer, 26(4):716-721.

Imesch, Patrick; Fink, Daniel (2016). Endometriosis Update 2016. Praxis, 105(5):253-257.

Pestalozzi, B; Fink, D (2016). Aszites. In: Kreuzer, Karl-Anton; Beyer, Jörg. Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Stuttgart: George Thieme Verlag, 88-89.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Botox für die Blase. Leading Opinions - Gynäkologie & Geburtshilfe:25-29.

Baege, Astrid; Ghisu, Gian-Piero; Betschart, Cornelia; Fink, Daniel (2016). Die HPV-Impfung und -Typisierung in der Primär- und Sekundärprävention: Stellenwert in der Praxis. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):20-24.

Fink, Daniel (2016). Editorial: Die Dysplasie-Sprechstunde. Gynäkologie, 4:1.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Erythrozyten im Harn. Internistische Praxis:673-680.

Leo, C; Fink, D (2016). Knoten in der Brust. In: Kreuzer, Karl-Anton; Beyer, Jörg. Hämatologie und Onkologie : fallorientierte Darstellung - rationale Diagnostik und Therapie. Stuttgart: George Thieme Verlag, 86-88.

Dedes, Konstantin J; Fink, Daniel (2016). Mammakarzinom in der Schwangerschaft. info@gynäkologie, 6:18-21.

Perucchini, Daniele; Scheiner, David A; Fink, Daniel; Betschart, Cornelia (2016). Management der Mischinkontinenz. Schritt für Schritt zum Erfolg – Diagnostik, Therapie, Beratung. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:15-20.

Ghisu, Gian-Piero; Fink, Daniel (2016). Medikamentös oder chirurgisch? State of the Art der Abortbehandlung in der Frühschwangerschaft. info@gynäkologie, 2:12-14.

Imesch, Patrick; Fink, Daniel (2016). Nachsorge in der gynäkologischen Onkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 5:6-9.

Dedes, K; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane. Vulvakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 399-400.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Endometriumkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 390-394.

Pestalozzi, Bernhard; Leo, Cornelia; Fink, Daniel (2016). Neoplasien der weiblichen Geschlechtsorgane: Mammakarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 373-385.

Dedes, K; Pestalozzi, B; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Ovarial- und Tubenkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 385-390.

Imesch, P; Fink, D (2016). Neoplasien der weiblichen Geschlechtsorgane: Zervixkarzinom. In: Kreuzer, K A; Beyer, J. Hämatologie und Onkologie. Fallorientierte Darstellung – rationale Diagnostik und Therapie. Stuttgart: Thieme, 395-399.

Betschart, Cornelia; Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2016). Normale und abnormale kolposkopische Befunde: Klassifikation und Bedeutung: Welche Befunde sind „gefährlich“? Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 2016(4):6-13.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2016). Rezidivierende Harnwegsinfekte : Komplikationen, Therapieoptionen, Prävention. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 3:6-14.

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Samartzis, E; Imesch, P; Twiehaus, A; Dubey, R K; Leeners, Brigitte (2016). The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen receptor independent manner. Gynecological Endocrinology, 32(7):529-533.

Ghisu, Gian-Piero; Baege, Astrid; Betschart, Cornelia; Fink, Daniel (2016). Therapie bei dysplastischen Veränderungen in der Gynäkologie. Schweizer Zeitschrift für Gynäkologie und Geburtshilfe in der Praxis, 4:14-19.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2016). Urininkontinenz und Sexualität. Hausarzt Praxis:2-4.

Ghisu, Gian-Piero; Fink, Daniel (2016). Verlauf der HPV-Infektion und Einteilung kolposkopischer Befunde. Gynaekologische Praxis, 41(2):187-199.

Del Prete, Valerio; Chaloupka, Karla; Holzmann, David; Fink, Daniel; Levesque, Mitchell; Dummer, Reinhard; Goldinger, Simone M (2015). Noncutaneous melanomas: a single-center analysis. Dermatology, 232(1):22-29.

Larsen, Dorthe Helena; Stucki, Manuel (2015). Nucleolar responses to DNA double-strand breaks. Nucleic Acids Research, 44(2):538-544.

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Vaso, Martin; Betschart, Cornelia; Egger, Herwig; Fink, Daniel; Schmidt, Ana-Maria (2015). Surgical technique of a recurrent post-radiation vesicovaginal fistula with a small intestine graft. Archives of Gynecology and Obstetrics, 292(3):485-488.

Scheiner, David A; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2015). Interstitial cystitis/bladder pain syndrome (IC/BPS). Praxis, 104(17):909-918.

Maurer, M M; Badir, S; Pensalfini, M; Bajka, M; Abitabile, P; Zimmermann, R; Mazza, E (2015). Challenging the in-vivo assessment of biomechanical properties of the uterine cervix: A critical analysis of ultrasound based quasi-static procedures. Journal of Biomechanics, 48(9):1541-1548.

Myers, Kristin M; Feltovich, Helen; Mazza, Edoardo; Vink, Joy; Bajka, Michael; Wapner, Ronald J; Hall, Timothy J; House, Michael (2015). The mechanical role of the cervix in pregnancy. Journal of Biomechanics, 48(9):1511-1523.

Ghisu, Gian-Piero; Fink, Daniel (2015). Burning vulva: significance of surgery in inflammatory and precancerous vulvar pathologies. Praxis, 104(13):689-693.

Bajka, M; Badir, S (2015). Fundus thickness assessment by 3D transvaginal ultrasound allows metrics-based diagnosis and treatment of congenital uterine anomalies. Ultraschall in der Medizin, 38(02):183-189.

Birindelli, Esther; Fink, Daniel (2015). Abnormal Early Pregnancy: What Matters for Practice. Praxis, 104(12):617-621.

Nikolopoulos, Kostis I; Betschart, Cornelia; Doumouchtsis, Stergios K (2015). The surgical management of recurrent stress urinary incontinence: a systematic review. Acta Obstetricia et Gynecologica Scandinavica, 94(6):568-576.

Stucki, Manuel (2015). TORC2 inhibition may boost DNA-damaging chemotherapy. OncoTarget, 6(2):586-587.

Fürer, K; et al; von Mandach, U (2015). Inhibition of porcine detrusor contractility by the flavonoid fraction of Bryophyllum pinnatum - a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine, 22(1):158-164.

Hempen, Aline; Samartzis, Eleftherios P; Kamarachev, Jivko; Fink, Daniel; Dedes, Konstantin J (2015). Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report. BMC Cancer, 15(507):online.

Imesch, Patrick; Fink, Daniel (2015). Aktuelle Diagnostik und operative Therapie der Endometriose in der Praxis. info@gynäkologie, 2015(3):18-20.

Kim, Jinyong; Betschart, Cornelia; Ramanah, Rajeev; Ashton-Miller, James A; DeLancey, John O L (2015). Anatomy of the pubovisceral muscle origin: Macroscopic and microscopic findings within the injury zone. Neurourology and Urodynamics, 34(8):774-780.

Agca, Cavit; Boldt, Karsten; Gubler, Andrea; Meneau, Isabelle; Corpet, Armelle; Samardzija, Marijana; Stucki, Manuel; Ueffing, Marius; Grimm, Christian (2015). Expression of leukemia inhibitory factor in Müller glia cells is regulated by a redox-dependent mRNA stability mechanism. BMC Biology, 13(1):30.

Sikora, Michal; Scheiner, David; Betschart, Cornelia; Perucchini, Daniele; Mateos, José María; di Natale, Anthony; Fink, Daniel; Maake, Caroline (2015). Label-free, three-dimensional multiphoton microscopy of the connective tissue in the anterior vaginal wall. International Urogynecology Journal and Pelvic Floor Dysfunction, 26(5):685-691.

Ihnenfeld Arciénega, Isabel; Imesch, Patrick; Fink, Daniel; Dedes, Konstantin J (2015). Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature. Targeted oncology, 10(2):297-301.

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Noske, Aurelia; Henricksen, Leigh A; LaFleur, Bonnie; Zimmermann, Anne-Katrin; Tubbs, Alisa; Singh, Shalini; Storz, Martina; Fink, Daniel; Moch, Holger (2014). Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes. Experimental and Molecular Pathology, 98(1):47-54.

Corpet, Armelle; Stucki, Manuel (2014). Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells. Chromosoma, 123(5):423-436.

Betschart, Cornelia; Kim, Jinyong; Miller, Janis M; Ashton-Miller, James A; DeLancey, John O L (2014). Comparison of muscle fiber directions between different levator ani muscle subdivisions: in vivo MRI measurements in women. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(9):1263-1268.

Larsen, Dorthe H; Hari, Flurina; Clapperton, Julie A; Gwerder, Myriam; Gutsche, Katrin; Altmeyer, Matthias; Jungmichel, Stephanie; Toledo, Luis I; Fink, Daniel; Rask, Maj-Britt; Grøfte, Merete; Lukas, Claudia; Nielsen, Michael L; Smerdon, Stephen J; Lukas, Jiri; Stucki, Manuel (2014). The NBS1-Treacle complex controls ribosomal RNA transcription in response to DNA damage. Nature Cell Biology, 16(8):792-803.

Samartzis, Eleftherios P; Gutsche, Katrin; Dedes, Konstantin J; Fink, Daniel; Stucki, Manuel; Imesch, Patrick (2014). Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. OncoTarget, 5(14):5295-5303.

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Natrajan, R; Wilkerson, P M; Marchiò, C; Piscuoglio, Salvatore; Lambros, M B; Samartzis, Eleftherios P; Dedes, Konstantin J (2014). Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. Journal of Pathology, 232(5):553-565.

Mazza, Edoardo; Parra-Saavedra, Miguel; Bajka, Michael; Gratacos, Eduard; Nicolaides, Kypros; Deprest, Jan (2014). In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy. Prenatal Diagnosis, 34(1):33-41.

Betschart, Cornelia; Rizk, Diaa E E (2014). Climbing a long hill: pelvic floor surgery and the need for geriatric urogynecology. International urogynecology journal and pelvic floor dysfunction, 25(3):297-298.

Strutas, Deivis; Betschart, Cornelia; Fink, Daniel (2014). Das Vestibulitissyndrom. Gynäkologie, 4:25-19.

Corpet, Armelle; Olbrich, Teresa; Gwerder, Myriam; Fink, Daniel; Stucki, Manuel (2014). Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle, 13(2):0-18.

Koppensteiner, Romana; Samartzis, Eleftherios P; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J (2014). Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro. PLoS ONE, 9(6):e100041.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Erythrozyten im Harn. Wie ist das weitere Vorgehen? Gynaekologische Praxis, 38(2):271-279.

Baege, Astrid; Ghisu, Gian-Piero; Fink, Daniel (2014). Follow-up nach Therapie einer CIN, einer VIN und einer VAIN. Gynäkologie, 4:20-24.

Ghisu, Gian-Piero; Baege, Astrid; Fink, Daniel (2014). HPV-assoziierte Genitalerkrankungen. Gynäkologie, 4:14-19.

Schnabel, J; Heuer, H; Dedes, K; Fink, D (2014). Hochrisikokonstellation für Brustkrebs. Schweizer Zeitschrift für Onkologie, 3:28-32.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 57-62.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Verlag, 37-56.

Imesch, Patrick; Fehr, Mathias; Fink, Daniel (2014). Maligne nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkomes). In: Petru, Edgar; Jonat, Walter; Fink, Daniel; Köchli, Ossi R. Praxisbuch Gynäkologische Onkologie. Heildelberg: Springer Verlag, 65-70.

Lohri, Corinne; Hutzli Schaltegger, Claudia S; van den Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Research, 34:4693-4700.

Fink, Daniel (2014). News from the San Antonio Breast Cancer Symposium 2013. Breast Care, 9(1):66-68.

Overactive Bladder: Fragen und Antworten. Edited by: Perucchini, Daniele (2014). Bremen: UNI-MED.

Fink, Daniel (2014). Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag.

Wiederer, Julia; Pazahr, Shila; Leo, Cornelia; Nanz, Daniel; Boss, Andreas (2014). Quantitative breast MRI: 2D histogram analysis of diffusion tensor parameters in normal tissue. Magma, 27(2):185-193.

Samartzis, Eleftherios P; Noske, Aurelia; Meisel, Alexander; Varga, Zsuzsanna; Fink, Daniel; Imesch, Patrick (2014). The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer. PLoS ONE, 9(1):e83296.

Luo, Jiajia; Betschart, Cornelia; Chen, Luyun; Ashton-Miller, James A; Delancey, John O L (2014). Using stress MRI to analyze the 3D changes in apical ligament geometry from rest to maximal Valsalva: a pilot study. International Urogynecology Journal and Pelvic Floor Dysfunction, 25(2):197-203.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2014). Vom Fettgift zum modernen Therapeutikum – Botulinumneurotoxine. info@gynäkologie, 5:20-22.

Betschart, Cornelia; Strutas, Deivis; Fink, Daniel (2014). Vulvadermatosen. Gynäkologie, 4:6-12.

Samartzis, Eleftherios P; Noske, Aurelia; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2013). ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. International Journal of Molecular Sciences, 14(9):18824-18849.

Ghisu, Gian-Piero; Fink, Daniel (2013). Frühaborte und Abruptiones. Operative und medikamentöse Therapie. Gynäkologie, (1):9-13.

Imesch, Patrick; Samartzis, Eleftherios P; Dedes, Konstantin J; Fink, Daniel; Fedier, André (2013). Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells. Fertility and Sterility, 100(3):770-776.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Botox in der Schwangerschaft und der Stillzeit. Hebamme.ch = Sage-femme.ch = Levatrice.ch = Spendrera.ch, (6):14-16.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Deszensuschirurgie. Neue und bewährte Techniken. Gynäkologie, (5):6-11.

Scheiner, David; Perucchini, Daniele; Fink, Daniel; Betschart, Cornelia (2013). Die Belastungsinkontinenz. Diagnostik und Therapie. Gynäkologie, (5):12-17.

Betschart, Cornelia; Perucchini, Daniele; Fink, Daniel; Scheiner, David (2013). Die Bildgebung des Beckenbodens. Ultraschall und MRI. Gynäkologie, (5):23-26.

Perucchini, Daniele; Betschart, Cornelia; Scheiner, David; Fink, Daniel (2013). Die überaktive Blase. Differenzialdiagnostik und therapeutisches Management. Gynäkologie, (5):18-22.

Imesch, Patrick; Fink, Daniel (2013). Das Endometriumkarzinom: Diagnostik und Therapie. Schweizer Zeitschrift für Onkologie, (4):2-6.

Scheiner, David; Betschart, Cornelia; Perucchini, Daniele (2013). Aktueller Stellenwert der Netzchirurgie. Fortbildung Genitaldeszensus. info@gynäkologie, 1:6-8.

Badir, Sabrina; Bajka, Michael; Mazza, Edoardo (2013). A novel procedure for the mechanical characterization of the uterine cervix during pregnancy. Journal of the Mechanical Behavior of Biomedical Materials, 27:143-153.

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Bajka, Michael (2013). Antikonzeption – Wo der Ultraschall massgeblich unterstützt. Praxis, 102(12):713-719.

Charpidou, Theodosia; Lang, Franziska; Langenegger, Thomas; Dedes, Konstantin J; Honegger, Christoph (2013). Bilateral transient osteoporosis of the knee during pregnancy. Archives of Gynecology and Obstetrics, 287(6):1259-1261.

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Imesch, Patrick; Scheiner, David; Szabo, Emese; Fink, Daniel; Fedier, André (2013). Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells. Experimental and Therapeutic Medicine, 6(3):786-790.

Imesch, Patrick; Scheiner, David; Xie, Min; Fink, Daniel; Macas, Erwin; Dubey, Raghvendra; Imthurn, Bruno (2013). Developmental potential of human oocytes matured in vitro followed by vitrification and activation. Journal of Ovarian Research, 6:30.

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Kohl Schwartz, A S; Leo, C; Rufibach, Kaspar; Varga, Z; Fink, D; Gabriel, N (2013). Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure? European Journal of Surgical Oncology, 39(3):266-272.

Zimmermann, Anne-Katrin; Imig, Jochen; Klar, Agnes; Renner, Christoph; Korol, Dimitri; Fink, Daniel; Stadlmann, Sylvia; Singer, Gad; Knuth, Alexander; Moch, Holger; Caduff, Rosmarie (2013). Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas. Virchows Archiv, 462(5):565-574.

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Nygaard, Christiana Campani; Betschart, Cornelia; Hafez, Ahmed A; Lewis, Erica; Chasiotis, Ilias; Doumouchtsis, Stergios K (2013). Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. International Urogynecology Journal and Pelvic Floor Dysfunction, 24(12):2071-2076.

Scheiner, David; Maggi, N; Perucchini, Daniele; Betschart, Cornelia (2013). Keimbefall bei Frauen mit und ohne OAB. Prävalenz von Urea- und Mycoplasmen, Gonokokken und Chlamydien im Urethralabstrich. Urologische Nachrichten, 3:9.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer. BioMed Research International, 2013:238284.

Betschart, C; Chen, L; Ashton-Miller, J A; Delancey, J O L (2013). On pelvic reference lines and the MR evaluation of genital prolapse: a proposal for standardization using the Pelvic Inclination Correction System. International urogynecology journal and pelvic floor dysfunction, 24(9):1421-1428.

Betschart, Cornelia; Mol, Suzanne E; Lütolf-Keller, Béatrice; Fink, Daniel; Perucchini, Daniele; Scheiner, David (2013). Pelvic floor muscle training for urinary incontinence: a comparison of outcomes in premenopausal versus postmenopausal women. Female Pelvic Medicine and Reconstructive Surgery, 19(4):219-224.

Betschart, Cornelia; von Mandach, Ursula; Seifert, Burkhardt; Scheiner, David; Perucchini, Daniele; Fink, Daniel; Geissbühler, Verena (2013). Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, 20(3-4):351-358.

Abascal, Federico; Corpet, Armelle; Gurard-Levin, Zachary A; Juan, David; Ochsenbein, Françoise; Rico, Daniel; Valencia, Alfonso; Almouzni, Geneviève (2013). Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b. Molecular Biology and Evolution, 30(8):1853-1866.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Samartzis, Eleftherios P; Noske, Aurelia; Samartzis, Nicolas; Fink, Daniel; Imesch, Patrick (2013). The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in Endometriosis. Reproductive Sciences, 20(12):1416-1422.

Teleki, Ivett; Krenacs, Tibor; Szasz, Marcell A; Kulka, Janina; Wichmann, Barna; Leo, Cornelia; Papassotiropoulos, Barbel; Riemenschnitter, Cosima; Moch, Holger; Varga, Zsuzsanna (2013). The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer, 13(1):50.

Ukegjini, Kristjan. Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients. 2012, University of Zurich, Faculty of Medicine.

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Betschart, C; Perucchini, D; Scheiner, D (2012). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Ars Medici, (III):23-26.

Fink, D (2012). Das Chamäleon unter den gynäkologischen Erkrankungen. Gynäkologie, (3):1.

Mueller, M; Eberhard, M; De Geyter, C; Häberlin, F; Hohl, M K; Imesch, P; Polli, C; Possover, M; Schiessl, K; Wenger, J M; Wunder, D (2012). Diagnostik und Therapie der Endometriose. Frauenheilkunde Aktuell, 21(2):28-34.

Samartzis, Nicolas; Samartzis, Eleftherios P; Noske, Aurelia; Fedier, Andre; Dedes, Konstantin J; Caduff, Rosmarie; Fink, Daniel; Imesch, Patrick (2012). Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study. Reproductive Biology and Endocrinology, 10:30.

Imesch, P; Fink, D (2012). Fertilitätserhaltende Therapien bei Ovarial- und Borderline-Tumoren. Leading Opinions Hämatologie & Onkologie, (5):52-54.

Fink, D (2012). Gatekeeper Frauenarztpraxis. Gynäkologie, (5):1.

Scheiner, D; Perucchini, D; Fink, Daniel; Betschart, C (2012). Gynäkologie: Fälle aus der Harninkontinenz-Sprechstunde. Praxis, 101(9):585-592.

Panel, Pierre; Bajka, Michael; Le Tohic, Arnaud; Ghoneimi, Alaa El; Chis, Carmen; Cotin, Stéphane (2012). Hysteroscopic placement of tubal sterilization implants: virtual reality simulator training. Surgical Endoscopy, 26(7):1986-1996.

Schmidt, A-M; Imesch, P; Fink, Daniel; Egger, H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecologic oncology, 125(3):604-609.

Leimbacher, B; Samartzis, N; Imesch, P; Dedes, K J; Fink, D; Canonica, C (2012). Inpatient and outpatient loop electrosurgery excision procedure for cervical intraepithelial neoplasia: a retrospective analysis. Archives of Gynecology and Obstetrics, 285(5):1441-1445.

Samartzis, Eleftherios P; Samartzis, Nicolas; Noske, Aurelia; Fedier, André; Caduff, Rosmarie; Dedes, Konstantin J; Fink, Daniel; Imesch, Patrick (2012). Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? Modern Pathology, 25(6):885-892.

Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E; Olivier, Jake; Caduff, Rosmarie; Scurry, James P; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A; Hacker, Neville F; Heinzelmann-Schwarz, Viola A (2012). Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS ONE, 7(2):e31885.

Hollenstein, M; Bajka, M; Röhrnbauer, B; Badir, S; Mazza, E (2012). Measuring the in vivo behavior of soft tissue and organs using the aspiration device. In: Payan, Y. Soft Tissue Biomechanical Modeling for Computer Assisted Surgery. Heidelberg: Springer, 201-228.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Gynäkologie, (3):17-21.

Imesch, P; Samartzis, E P; Fink, D (2012). Medikamentöse Therapie der Endometriose. Ars Medici, (18):934-937.

Imesch, P; Fink, D (2012). Nachsorge in de gynäkologischen Onkologie. Gynäkologie, (5):6-9.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 1: Abklärung bei Harninkontinenz und Genitaldeszensus. Gynäkologie, (2):34-38.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 2: Die Behandlung bei Genitaldeszensus. Gynäkologie, (3):34-38.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 3: Die Behandlung bei Belastungsinkontinenz. Gynäkologie, (4):31-36.

Betschart, C; Scheiner, D; Perucchini, D (2012). Nr. 4: Die Behandlung bei überaktiver Blase. Gynäkologie, (5):21-24.

Church, D N; Koppensteiner, R; Yap, T; Fink, Daniel; Dedes, K J (2012). P13K-AKT-mTOR inhibitors for the systematic treatment of endometrial cancer. Expert Review of Obstetrics & Gynecology, 7(5):421-430.

Samartzis, E P; Imesch, P; Fink, D (2012). Pathogenese der Endometriose. Gynäkologie, (3):6-10.

Dedes, K J; Fink, Daniel; Steiner, R A (2012). Principes de la chimiothérapie. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 50-54.

Imesch, P; Samartzis, E P; Fink, D (2012). Prävalenz, Diagnostik und Therapie der Endometriose. info@gynäkologie, (3):19-21.

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Fink, Daniel; Leo, C (2012). Synopsis des principales études concernant le traitement du cancer du sein au stade métastatique. In: Hornung, R; Fink, Daniel. Traitement de deuxième intention du cancer du sein. Bremen: UNI-MED Verlag, 72-82.

Chirgwin, J; Sun, Z; Smith, I; Price, K N; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, M M; Goldhirsch, A; Coates, A S (2012). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Research and Treatment, 131(1):295-306.

Jungmichel, Stephanie; Clapperton, Julie A; Lloyd, Janette; Hari, Flurina J; Spycher, Christoph; Pavic, Lucijana; Li, Jiejin; Haire, Lesley F; Bonalli, Mario; Larsen, Dorthe H; Lukas, Claudia; Lukas, Jiri; MacMillan, Derek; Nielsen, Michael L; Stucki, Manuel; Smerdon, Stephen J (2012). The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator. Nucleic Acids Research, 40(9):3913-3928.

Schneider, Priska; von Orelli, Stephanie; Roos, Malgorzata; Leo, Cornelia; Fink, Daniel; Wyss, Pius (2012). The value of endocervical curettage after conization for cervical intraepithelial neoplasia. Annals of Diagnostic Pathology, 16(4):245-249.

Fink, D (2012). Therapie des Ovarialkarzinoms. Leading Opinions Medizin für die Frau, (3):31-32.

Scheiner, D A; Betschart, C; Wiederkehr, S; Seifert, Burkhardt; Fink, D; Perucchini, D (2012). Twelve months effect on voiding function of retropubic compared with outside-in and inside-out transobturator midurethral slings. International Urogynecology Journal, 23(2):197-206.

Imesch, P; Fink, D; Gabriel, N (2012). Was bringt ein Screening beim Ovarial- und Korpus-Ca? Leading Opinions Medizin für die Frau, (3):28-30.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

Fink, D; Fehr, M K (2011). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 133-140.

Fehr, M K; Fink, D (2011). Karzinosarkome des Uterus (maligne Müller-Mischtumoren des Uterus, maligne mesodermale Mischtumoren, maligne gemischte mesenchymale Tumoren). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 57-62.

Fehr, M K; Fink, D (2011). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch Gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 40-55.

Fehr, M K; Fink, D (2011). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O R. Praxisbuch gynäkologische Onkologie (3. Aufl.). Berlin, DE: Springer, 64-69.

Meier, Mara Isabella Eva. No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. 2011, University of Zurich, Faculty of Medicine.

Burger, I A; Scheiner, D A; Crook, D W; Treyer, V; Hany, T F; von Schulthess, G K (2011). FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position. European Journal of Nuclear Medicine and Molecular Imaging, 38(1):90-96.

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

Noske, A; Zimmermann, A K; Caduff, R; Varga, Z; Fink, D; Moch, H; Kristiansen, G (2011). Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer. Virchows Archiv, 459(1):91-97.

Betschart, C; Perucchini, D; Scheiner, D (2011). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Gynäkologie, (2):11-14.

Betschart, C; Perucchini, D; Scheiner, D (2011). Altersadaptierte Urogynäkologie: Krankheitsbilder, Evaluation und Management der Blase im Alter. Ars Medici, (15):619-623.

Regan, M M; Neven, P; Giobbie-Hurder, A; Goldhirsch, A; Ejlertsen, B; Mauriac, L; Forbes, J F; Smith, I; Láng, I; Wardley, A; Rabaglio, M; Price, K N; Gelber, R D; Coates, A S; Thürlimann, B (2011). Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncology, 12(12):1101-1108.

Fink, D (2011). Beratung zur Prävention – stetiger Diskussionsstoff. Gynäkologie, (4):1.

Achtari, C; Fink, D; Günthert, A R; Huober, J; Pestalozzi, B; Petignat, P; von Moos, R; Sessa, C (2011). Bevacizumab in the primary treatment of epithelial ovarian cancer – some comments on the latest results. Schweizer Krebs-Bulletin = Bulletin Suisse du Cancer, 35(1):35-38.

von Mandach, U; Betschart, C (2011). Bryophyllum pinnatum in der Geburtshilfe und Gynäkologie. Wirksamkeit und Verträglichkeit. info@gynäkologie, (3):16-20.

Toller, I M; Neelsen, K J; Steger, M; Hartung, M L; Hottiger, M O; Stucki, M; Kalali, B; Gerhard, M; Sartori, A A; Lopes, M; Müller, A (2011). Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 108(36):14944-14949.

Pochechueva, T; Jacob, F; Goldstein, D R; Huflejt, M E; Chinarev, A; Caduff, R; Fink, D; Hacker, N; Bovin, N V; Heinzelmann-Schwarz, V (2011). Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies. Glycoconjugate Journal, 28(8-9):507-517.

Imesch, P; Hornung, R; Fink, D; Fedier, A (2011). Cordycepin (3'-Deoxyadenosine), an Inhibitor of mRNA Polyadenylation, Suppresses Proliferation and Activates Apoptosis in Human Epithelial Endometriotic Cells in vitro. Gynecologic and Obstetric Investigation, 72(1):43-49.

Heinzelmann-Schwarz, V (2011). Das epitheliale Ovarialkarzinom – ein Paradigmenwandel. Therapeutische Umschau, 68(10):565-572.

Schlatter, C (2011). Der aufsteigende Genitalinfekt: Aktuelle Diagnostik- und Therapiekonzepte. Gynäkologie, (4):20-23.

Dedes, K J; Natrajan, R; Lambros, M B; Geyer, F C; Lopez-Garcia, M A; Savage, K; Jones, R L; Reis-Filho, J S (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. European Journal of Cancer, 47(1):138-150.

Dedes, K J; Wetterskog, D; Ashworth, A; Kaye, S B; Reis-Filho, J S (2011). Emerging therapeutic targets in endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):261-271.

Imesch, P; Samartzis, E P; Fink, D (2011). Endometriose - eine epigenetische Erkrankung? Leading Opinions - Medizin für die Frau, 4(1):2-4.

Leo, C; Fink, D (2011). Epithelial-zu-mesenchymale Transition (EMT) - Neue molekulare Einsichten in die Tumorprogression. Geburtshilfe und Frauenheilkunde, 71(01):21-25.

Leo, C; Fink, D (2011). Erythropoietin in der onkologischen Therapie – was wissen wir über die Risiken? Praxis, 100(20):1239-46.

Samartzis, N; Imesch, P; Dedes, K J; Samartzis, E P; Fedier, A; Fink, D; Caduff, R; Fehr, M K (2011). Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. BMC Cancer, 11:463.

Wilkerson, P M; Dedes, K J; Wetterskog, D; Mackay, A; Lambros, M B; Mansour, M; Frankum, J; Lord, C J; Natrajan, R; Ashworth, A; Reis-Filho, J S (2011). Functional characterization of EMSY gene amplification in human cancers. Journal of Pathology, 225(1):29-42.

Brough, R; Frankum, J R; Sims, D; Mackay, A; Mendes-Pereira, A M; Bajrami, I; Costa-Cabral, S; Rafiq, R; Ahmad, A S; Cerone, M A; Natrajan, R; Sharpe, R; Shiu, K K; Wetterskog, D; Dedes, K J; Lambros, M B; Rawjee, T; Linardopoulos, S; Reis-Filho, J S; Turner, N C; Lord, C J; Ashworth, A (2011). Functional viability profiles of breast cancer. Cancer Discovery, 1(3):260-273.

Betschart, C; Kerl, K; Fink, D (2011). Harninkontinenz macht nicht nur nass! Diagnose und Therapie lokaler Begleiterkrankungen der Harninkontinenz. Leading Opinions - Medizin für die Frau, 4:26-29.

Imesch, P; Samartzis, E P; Schneider, M; Fink, D; Fedier, A (2011). Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertility and Sterility, 95(5):1579-1583.

Regan, M M; Price, K N; Giobbie-Hurder, A; Thürlimann, B; Gelber, R D (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast Cancer Research, 13(3):209.

Fink, D; Hutzli Schaltegger, C (2011). Intraoperative Radiotherapie: Neue Therapieoption beim Mammakarzinom. Kongress Special, (5-6):9.

Gabriel, N; Fink, D (2011). Lifestyleänderungen nach Mammakarzinom. Empfohlene Massnahmen und Fragen in der Beratung. Gynäkologie, (4):6-9.

Imesch, P; Goehrens, A; Fink, D; Fedier, A (2011). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine)in vitro. Oncology Letters, 3(2):441-444.

Fink, D (2011). Mamma-Screening: Ältere Studien sprechen dafür, neue warnen. Kongress Special, (3-4):9.

Hirsch, S; Szczerba, D; Lloyd, B; Bajka, M; Kuster, N; Székely, G (2011). Mechano-chemical simulation of solid tumor dynamics for therapy outcome predictions. International Journal for Multiscale Computational Engineering, 9(2):231-241.

Pochechueva, T; Chinarev, A; Spengler, M; Korchagina, E; Heinzelmann-Schwarz, V; Bovin, N; Rieben, R (2011). Multiplex suspension array for human anti-carbohydrate antibody profiling. The Analyst, 136(3):560-569.

Betschart, C (2011). Neue Therapieoptionen gegen verstärkte uterine Blutungen. Vorgehen bei Hypermenorrhoe. info@gynäkologie, (1):36-37.

Jacob, F; Meier, M; Caduff, R; Goldstein, D; Pochechueva, T; Hacker, N; Fink, D; Heinzelmann-Schwarz, V (2011). No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecologic Oncology, 121(3):487-491.

Dedes, K J; Fink, D (2011). Ovarial-, Zervix- und Vulvakarzinom: Neues zu gynäkologischen Tumoren. Hausarzt Praxis, 8(15):15-18.

Betschart, C; Scheiner, D; Hess, E; Seifert, Burkhardt; Fink, D; Perucchini, D (2011). Patient satisfaction after retropubic and transobturator slings: first assessment using the Incontinence Outcome Questionnaire (IOQ). International Urogynecology Journal, 22(7):805-812.

Kut, E; Candia, V; von Overbeck, J; Pok, J; Fink, D; Folkers, G (2011). Pleasure-related analgesia activates opioid-insensitive circuits. Journal of Neuroscience, 31(11):4148-53.

Leo, C; Fink, D (2011). Prävention und Screening beim Mammakarzinom. Pro und Kontra des Mammografiescreenings. Schweizer Zeitschrift für Onkologie, (3):6-9.

Betschart, C; Scheiner, D; Fink, D (2011). Reizblase bei der Frau: Neue Therapieansätze. Hausarzt Praxis, (8):30-32.

Papadatos-Pastos, D; Dedes, K J; de Bono, J S; Kaye, S B (2011). Revisiting the role of antiandrogen strategies in ovarian cancer. The Oncologist, 16(10):1413-1421.

Fink, D; Leo, C (2011). Synopsis grösserer Studien zur Therapie des metastasierten Mammakarzinoms. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 70-79.

Dedes, K J; Wilkerson, P M; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, J S (2011). Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle, 10(8):1192-1199.

Dedes, K J; Fink, D; Steiner, R (2011). Systemische Tumorkontrolle: Chemotherapeutische Prinzipien. In: Hornung, R; Fink, D. Zweitlinientherapie des Mammakarzinoms. Bremen, DE: UNI-MED Verlag, 47-52.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2011). TVT, TOT und TVT-O: Schweizer 1-Jahres-Resultate. Vergleich verschiedener Schlingen bei Inkontinenz. Leading Opinions - Medizin für die Frau, 4(3):26-29.

Schwager, K; Bootz, F; Imesch, P; Kaspar, M; Trachsel, E; Neri, D (2011). The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Human Reproduction, 26(9):2344-2352.

Forster, M D; Dedes, K J; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C J; Weigelt, B; Kaye, S B; Rhoda Molife, L (2011). Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nature Reviews. Clinical Oncology, 8(5):302-306.

Theurillat, J P; Metzler, S C; Henzi, N; Djouder, N; Helbling, M; Zimmermann, A K; Jacob, F; Soltermann, A; Caduff, R; Heinzelmann-Schwarz, V; Moch, H; Krek, W (2011). URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell, 19(3):317-332.

Imesch, P; Fink, D (2011). Zervixkarzinom. Therapeutische Umschau, 68(10):545-552.

Bajka, M (2011). Zystischer Unterbauchtumor. Praxis, 100(25):1543-1548.

Barchiesi, F; Lucchinetti, E; Zaugg, M; Ogunshola, O O; Wright, M; Meyer, Markus; Rosselli, M; Schaufelberger, S; Gillespie, D G; Jackson, E K; Dubey, R K (2010). Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension, 56(5):964-972.

Gabriel, N; Fink, D (2010). 32nd San Antonio Breast Cancer Symposium: Highlights aus San Antonio. Leading Opinions. Medizin für die Frau, 3(2):39-40.

Betschart, C; Scheiner, D; Fink, D; Peruccini, D (2010). Overactive Bladder: Individuelles Stufenkonzept in Abklärung und Therapie. Leading Opinions. Medizin für die Frau, 3(2):18-20.

Pók, J (2010). Was lässt Frauenbrüste schmerzen? Ursachen und Differenzialdiagnose der Mastodynie. Ars Medici, (9):372-373.

Fink, D (2010). Therapie des Mammakarzinoms – Wandel von der radikalen zur qualitätskontrollierten individualisierten Therapie. Praxis, 99(7):397-398.

Scheiner, D; Betschart, C; Perucchini, D (2010). Altersabhängige Veränderungen des Beckenbodens bei der Frau. Therapeutische Umschau, 67(1):23-26.

Betschart, C; Scheiner, D; Fink, D (2010). Basisabklärung: Wann ist eine Urodynamik sinnvoll? : Diagnostik bei Harninkontinenz und Drangbeschwerden. Gynäkologie, (2):21-25.

Pók, J (2010). Basiswissen Medizin und Genetik. In: Pók, J; Baumann-Hölzle, R; Ritzenthaler, D; Dialog Ethik Zürich. Psychosoziale Beratung bei vorgeburtlichen Untersuchungen : Anleitung für die Beratungspraxis ergänzt mit interdisziplinärem Fachwissen. Zürich: Dialog Ethik, 39-46.

Dedes, K J; Lopez-Garcia, M A; Geyer, F C; Lambros, M B K; Savage, K; Vatcheva, R; Wilkerson, P; Wetterskog, D; Lacroix-Triki, M; Natrajan, R; Reis-Filho, J S (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment, 124(3):653-666.

Blank, P R; Dedes, K J; Szucs, T D (2010). Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review. PharmacoEconomics, 28(8):629-647.

Scheiner, D (2010). Die überaktive Blase. In: Tunn, R; Hanzal, E; Perucchini, D. Urogynäkologie in Praxis und Klinik (2. Aufl.). Berlin, DE: de Gruyter, 185-215.

Imesch, P; Samartzis, E P; Fink, D (2010). Endometriose – eine epigenetische Erkrankung? Endometriose Aktuell, (2):2-4.

Imesch, P; Fink, D (2010). Endometriose: Richtiges operatives Vorgehen bei unerfülltem Kinderwunsch. Leading Opinions. Medizin für die Frau, 3(3):10-12.

Bajka, M; Tuchschmid, S; Fink, D; Székely, G; Harders, M (2010). Establishing construct validity of a virtual-reality training simulator for hysteroscopy via a multimetric scoring system. Surgical Endoscopy, 24(1):79-88.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Scheiner, D; Betschart, C; Fink, D; Perucchini, D (2010). Langzeiterfahrung mit intravesikaler Botoxinjektion : Anwendung bei therapierefraktärer idiopathischer OAB-Symptomatik. Gynäkologie, (3):2-6.

Höckel, M; Kahn, T; Einenkel, J; Manthey, N; Braumann, U D; Hildebrandt, G; Leo, C; Hentschel, B; Vaupel, P; Horn, L C (2010). Local spread of cervical cancer revisited: a clinical and pathological pattern analysis. Gynecologic Oncology, 117(3):401-408.

Lambros, M B; Natrajan, R; Geyer, F C; Lopez-Garcia, M A; Dedes, K J; Savage, K; Lacroix-Triki, M; Jones, R L; Lord, C J; Linardopoulos, S; Ashworth, A; Reis-Filho, J S (2010). PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Modern Pathology, 23(10):1334-1345.

Dedes, K J; Wetterskog, D; Mendes-Pereira, A M; Natrajan, R; Lambros, M B; Geyer, F C; Vatcheva, R; Savage, K; Mackay, A; Lord, C J; Ashworth, A; Reis-Filho, J S (2010). PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Science Translational Medicine, 2(53):53ra75.

Fritzsche, F R; Reineke, T; Morawietz, L; Kristiansen, G; Dietel, M; Fink, D; Rageth, C; Honegger, C; Caduff, R; Moch, H; Varga, Z (2010). Pathological processing techniques and final diagnosis of breast cancer sentinel lymph nodes. Annals of Surgical Oncology, 17(11):2892-2898.

Kind, C; Pok, J (2010). Praktische Anwendung der pränatalen und präimplantativen Diagnostik. In: Kind, C; Braga, S; Studer, A. Auswählen oder annehmen? Zürich: Chronos Verlag, 43-62.

Imesch, P; Fink, D; Fedier, A (2010). Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertility and Sterility, 94(7):2838-2842.

Peruccini, D; Betschart, C; Fink, D; Scheiner, D (2010). Schlingenoperationen bei Belastungsinkontinenz: Reicht eine einzige Schlinge für alle Indikationen? Leading Opinions. Medizin für die Frau, 3(2):22-26.

Schlatter, C (2010). Sexualmedizinische Betreuung von Risikopatientinnen. Ars Medici, (1):22-25.

Hanzal, E; Scheiner, D (2010). Therapie der Belastungsinkontinenz. In: Tunn, R; Hanzal, E; Perucchini, D. Urogynäkologie in Praxis und Klinik (2. Aufl.). Berlin, DE: de Gruyter, 161-184.

Matter-Walstra, K W; Dedes, K J; Schwenkglenks, M; Brauchli, P; Szucs, T D; Pestalozzi, B C (2010). Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21(11):2161-2168.

Scheiner, D Urogynäkologie in Klinik und Praxis (2., völlig neu verf. Aufl.). Edited by: Tunn, R; Hanzal, E; Perucchini, D (2010). Berlin, DE: de Gruyter.

Betschart, C; Perucchini, D (2010). Überaktive Blase: Management in der Praxis. Gynäkologie, (2):26-28.

Jacob, F; Goldstein, D R; Fink, D; Heinzelmann-Schwarz, V (2009). Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs. Biomarkers in Medicine, 3(6):743-756.

Szucs, Thomas D; Dedes, Konstantin J (2009). Is cancer prevention ever going to be profitable? In: Senn, H J; Kapp, U; Ott, F. Cancer Prevention II. Berlin: Springer, 41-47.

Bajka, M; Tuchschmid, S; Streich, M; Fink, D; Székely, G; Harders, M (2009). Evaluation of a new virtual-reality training simulator for hysteroscopy. Surgical Endoscopy, 23(9):2026-2033.

Bajka, M; Weiss, S; Kunz, J; Fischer, H; Székely, G; Niederer, P (2009). Pressure-dependent hydrometra dimensions in hysteroscopy. Surgical Endoscopy, 23(9):2102-2109.

Matzinger, B; Wolf, M; Baños, A; Fink, D; Hornung, R (2009). Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers in Medical Science, 24(4):561-566.

Dedes, K J; Dedes, I; Imesch, P; von Bueren, A O; Fink, D; Fedier, A (2009). Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities. Anti-Cancer Drugs, 20(5):321-333.

Dedes, K J; Matter-Walstra, K; Schwenkglenks, M; Pestalozzi, B C; Fink, D; Brauchli, P; Szucs, T D (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation. European Journal of Cancer, 45(8):1397-1406.

Müller, M K; Dedes, K J; Dindo, D; Steiner, S; Hahnloser, D; Clavien, P A (2009). Impact of clinical pathways in surgery. Langenbeck's Archives of Surgery, 394(1):31-39.

Schlatter Gentinetta, C (2009). Abklärung nach sexueller Gewalt bei Migrantinnen: Problematik, Vertrauensbildung, ärztliches Vorgehen. Gynäkologie, (5):13-15.

Langer, I; Guller, U; Berclaz, G; Koechli, O R; Moch, H; Schaer, G; Fehr, M K; Hess, T; Oertli, D; Bronz, L; Schnarwyler, B; Wight, E; Uehlinger, U; Infanger, E; Burger, D; Zuber, M (2009). Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study. Breast Cancer Research and Treatment, 113(1):129-136.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2009). Anticholinerge Therapie der hyperaktiven Blase. Ars Medici, (3):18-23.

Bauer, M; Mazza, E; Jabareen, M; Sultan, L; Bajka, M; Lang, U; Zimmermann, R; Holzapfel, G A (2009). Assessment of the in vivo biomechanical properties of the human uterine cervix in pregnancy using the aspiration test: a feasibility study. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144(Suppl ):S77-S81.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Dedes, K J; Fink, D (2009). Clinical Presentation and Surgical Management of Invasive Lobular Carcinoma of the Breast. Breast Disease, 30:31-37.

Horn, L-C; Hentschel, B; Meinel, A; Alexander, H; Leo, C (2009). Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions. Annals of Diagnostic Pathology, 13(6):373-377.

Giobbie-Hurder, A; Price, K N; Gelber, R D; et al; Varga, Z; Moch, H; Caduff, R (2009). Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer. Clinical Trials, 6(3):272-287.

Schlatter Gentinetta, C (2009). Dissonanzen. Schweizerische Ärztezeitung, 90(12):498.

Fink, D; Lang, U; Kimmig, R (2009). Einsatz der Laparoskopie in der gynäkologischen Onkologie. Gynäkologisch-Geburtshilfliche Rundschau, 49(3):109-110.

Pók, J (2009). Gynäkologie im Kontext der Migration. Gynäkologie, (5):1.

Schneider-Yin, Xiaoye; Kurmanaviciene, Aida; Roth, Marion; Roos, Malgorzata; Fedier, André; Minder, Elisabeth I; Walt, Heinrich (2009). Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis and Photodynamic Therapy, 6(1):12-18.

Lang, U; Fink, D; Kimmig, R (2009). Intrauterine Programmierung spezifischer Organsysteme. Gynäkologisch-geburtshilfliche Rundschau, 49(1):1.

Fehr, M K; Fink, D (2009). Karzinosarkome des Uterus, maligne Müller-Mischtumoren des Uterus, Maligne mesodermale Mischtumoren, Maligne gemischte mesenchymale Tumoren (MMMT). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 53-58.

Imesch, P; Dedes, K; Fink, D (2009). Laparoskopische Therapie des Korpuskarzinoms: Datenlage und Evidenz. Gynäkologisch-geburtshilfliche Rundschau, 49(3):111-116.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Imesch, P; Dedes, K J; Furlato, M; Fink, D; Fedier, A (2009). MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. International Journal of Oncology, 35(3):631-640.

Fehr, M K; Fink, D (2009). Maligne epitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 33-51.

Fink, D; Fehr, M K (2009). Maligne nichtepitheliale Tumoren des Ovars. In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 133-141.

Fehr, M K; Fink, D (2009). Maligne, nichtepitheliale Tumoren des Corpus uteri (ausschliesslich des Karzinosarkoms). In: Petru, E; Jonat, W; Fink, D; Köchli, O. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer Medizin Verlag GmbH, 59-65.

Gabriel, N; Fink, D (2009). Management des Mammakarzinoms Nebenwirkungen der endokrinen Therapie. Leading Opinions. Medizin für die Frau, 3:26-28.

Pók, J (2009). Mastodynie: Was lässt Frauenbrüste schmerzen? Der Allgemeinarzt, (12):34-35.

Imthurn, B; Kimmig, R; Lang, U; Fink, D (2009). Neue Entwicklungen in der Fortpflanzungsmedizin. Gynäkologisch-geburtshilfliche Rundschau, 49(2):53-44.

Stahel, M C; Wolf, M; Baños, A; Hornung, R (2009). Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles. Lasers in Medical Science, 24(6):901-907.

Praxisbuch Gynäkologische Onkologie. Edited by: Petru, E; Jonat, W; Fink, D; Köchli, O (2009). Heidelberg: Springer Medizin Verlag GmbH.

Schlatter Gentinetta, C (2009). Sexualmedizin: Betreuung von Risikopatientinnen. Der Allgemeinarzt, (16):42-45.

van Dalen, A; Favier, J; Hallensleben, E; Burges, A; Stieber, P; de Bruijn, H W A; Fink, D; Ferrero, A; McGing, P; Harlozinska, A; Kainz, C; Markowska, J; Molina, R; Sturgeon, C; Bowman, A; Einarsson, R; Goike, H (2009). Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up. European Journal of Gynaecological Oncology, 30(6):609-615.

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Niederer, P; Weiss, S; Caduff, R; Bajka, M; Szekély, G; Harders, M (2009). Uterus models for use in virtual reality hysteroscopy simulators. European Journal of Obstetrics and Gynecology and Reproductive Biology, 144, S:S90-S95.

Betschart, C; Scheiner, D; Maake, C; Vich, M; Slomianka, L; Fink, D; Perucchini, D (2008). Histomorphological analysis of the urogenital diaphragm in elderly women: a cadaver study. International Urogynecology Journal, 19(11):1477-1481.

Scheiner, D (2008). Quid novi sub sole?: Streiflichter vom 37. Treffen der International Continence Society, Rotterdam, 20.-24. August 2007. In: 37. Treffen der International Continence Society, Rotterdam, 20 August 2008 - 22 August 2008, 51-53.

Schmid, D M; Roy, S; Sulser, T; Scheiner, D (2008). Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity. BJU International, 102(Suppl ):7-10.

Szucs, T D; Largeron, N; Dedes, K J; Rafia, R; Bénard, S (2008). Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Current Medical Research and Opinion, 24(5):1473-1483.

Varga, Z; Rageth, C; Saurenmann, E; Honegger, C; von Orelli, S; Fehr, M; Fink, D; Seifert, Burkhardt; Moch, H; Caduff, R (2008). Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer. Histopathology, 52(5):597-604.

Viale, G; Regan, M M; Maiorano, E; Stahel, R A (2008). Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Journal of Clinical Oncology, 26(9):1404-1410.

Fink, D (2008). Adjuvante Systemtherapie und Tumornachsorge beim Mammakarzinom: State of the Art 2007. In: Redaelli, C. IZS Jahrbuch 2007. Zürich: Interdisziplinäres Zürcher Symposium, 49-61.

Dedes, K J; Gabriel, N; Fink, D (2008). Aktuelle adjuvante endokrine Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):130-137.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

Perucchini, D; Scheiner, D; Betschart, C; Fink, D (2008). Anticholinerge Therapie der hyperaktiven Blase: Wie wird optimiert? Gynäkologie, (5):23-28.

Szucs, T D; Dedes, K J (2008). Balancing costs and benefits in cancer therapy and prevention. Annals of Oncology, 19(Suppl.):vii313-vii319.

Mazza, E; Grau, P; Hollenstein, M; Bajka, M (2008). Constitutive modeling of human liver based on in vivo measurements. In: Metaxas, D. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2008. Berlin / Heidelberg: Springer, 726-733.

Sinha, C; Köhler, H; Fink, D (2008). Continuous Medical Education. Praxis, 97(25):1321-1328; quiz 1329-1330.

Imesch, P; Fink, D (2008). Das Endometriumkarzinom: Epidemiologie, Präkanzerosen, Diagnostik, Therapie und Nachsorge. Schweizer Zeitschrift für Onkologie, (5):6-10.

Schmidt, A M; Fink, D (2008). Das Ovarialkarzinom: Aktuelle Therapiestrategien im frühen und fortgeschrittenen Stadium. Schweizer Zeitschrift für Onkologie, (5):12-14.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Das Urethralsyndrom: Prävalenz, Differenzialdiagnose,Therapie. Gynäkologie, (2):14-16.

Pók, J (2008). Designer Babys? Bioethica Forum, 1(2):104-105.

Schlatter Gentinetta, C (2008). Die Nachsorge bei gynäkologischen Tumoren: Empfehlungen nach der Primärtherapie bei typischen Beschwerden und Risiken. Schweizer Zeitschrift für Onkologie, (5):21-25.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Lang, U; Fink, D; Kimmig, R (2008). Fetale Programmierung = Fetal programming. Gynäkologisch-Geburtshilfliche Rundschau, 48(4):205-206.

Fink, D (2008). Ideal in der Praxis: die gynäkologisch-onkologische Nachsorge. Schweizer Zeitschrift für Onkologie, (5):1.

Viereck, V; Eberhard, J (2008). Inkontinenzoperationen - Indikationen, Auswahl der Operationsmethode, Operationstechnik, Umgang mit Früh- und Spätkomplikationen. Journal für Urologie und Urogynäkologie, 15(3):37-42.

Weiss, S; Niederer, P; Navarini, A; Caduff, R; Bajka, M (2008). Inverse finite element characterization of the human myometrium derived from uniaxial compression experiments. Biomedizinische Technik. Biomedical Engineering, 53(2):52-58.

Betschart, C; Scheiner, D; Fink, D; Perucchini, D (2008). Konservative Therapie von Harninkontinenz, Drangsymptomen und Genitaldeszensus. Journal für Urologie und Urogynäkologie, 15(3):23-30.

Kimmig, R; Fink, D; Lang, U (2008). Körperliche Integrität versus onkologische Sicherheit: Synthese wichtiger Aspekte in der Therapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(2):55.

Tuchschmid, S; Bajka, M; Szczerba, D; Lloyd, B A; Székely, G; Harders, M (2008). Modeling intravasation of liquid distension media in surgical simulators. Medical Image Analysis, 12(5):567-576.

Scheiner, D; Betschart, C; Zachmann, S; Fink, D; Perucchini, D (2008). Moderne Schlingentechniken bei Belastungsinkontinenz: Technik, Studienresultate, Komplikationen, Differenzialindikation. Gynäkologie, (2):17-22.

Gabriel, N (2008). Nebenwirkungen der endokrinen Therapie beim Mammakarzinom: Erkennen, Vorsorgen und Behandeln. Schweizer Zeitschrift für Onkologie, (5):16-20.

Dedes, K J; Beneder, C; Samartzis, N; Muller, M D; Fink, D; Fehr, M K (2008). Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women. Journal of Reproductive Medicine, 53(12):947-951.

Overactive Bladder - Fragen und Antworten. Edited by: Perucchini, D (2008). Bremen: UNI-MED Verlag AG.

Petignat, P; Stucki, D; Altermatt, H J; Seydoux, J; Jacob, S; Brioschi, P A; Fink, D; Fehr, M; Delaloye, J F; Loubeyre, P; Hohl, M; Mueller, M; Dubuisson, J B (2008). Place de la laparoscopie dans le traitement du cancer de l'endomètre. Revue Médicale Suisse, 4(153):995-998.

Viale, G; Giobbie-Hurder, A; Regan, M M; Stahel, R A (2008). Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Journal of Clinical Oncology, 26(34):5569-5575.

Pók, J (2008). Pränatale Diagnostik im Spitalalltag. In: Hürlimann, D C; Baumann-Hölzle, R; Müller, H. Der Beratungsprozess in der Pränatalen Diagnostik. Bern: Peter Lang AG, 165-172.

Fedier, A. Strategies for prevention, circumvention, and reversal of drug resistance in tumor cells. 2008, University of Zurich, Faculty of Medicine.

Kociszewski, J; Rautenberg, O; Perucchini, D; Eberhard, J; Geissbühler, V; Hilgers, R; Viereck, V (2008). Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourology and Urodynamics, 27(6):485-490.

O'Brien, P M; Davies, M J; Scurry, J P; Smith, A N; Barton, C A; Henderson, M J; Saunders, D N; Gloss, B S; Patterson, K I; Clancy, J L; Heinzelmann-Schwarz, V A; Murali, R; Scolyer, R A; Zeng, Y; Williams, E D; Scurr, L; Defazio, A; Quinn, D I; Watts, C K W; Hacker, N F; Henshall, S M; Sutherland, R L (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. British Journal of Cancer, 98(6):1085-1093.

Blochlinger-Wegmann, B; Werner, M; Scheiner, D; Fink, D; Perucchini, D (2008). Urethraldivertikel als Ursache chronischer urogenitaler Schmerzen: Ein Fallbericht. Gynäkologisch-Geburtshilfliche Rundschau, 48(1):35-37.

Eberhard, J (2008). Urogenitale Beschwerden - Häufige Frauenleiden. Journal für Urologie und Urogynäkologie, 15(3):4-5.

Fink, D; Lang, U; Kimmig, R (2008). Wichtige Fortschritte in der adjuvanten Systemtherapie des Mammakarzinoms. Gynäkologisch-geburtshilfliche Rundschau, 48(3):111-112.

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Degen Iseli, Andrea Franziska; Gabrecht, Tanja; Mosimann, Laurent; Fehr, Mathias K; Hornung, René; Schwarz, Viola A; Tadir, Yona; Steiner, Rolf A; Wagnières, Georges; Wyss, Pius (2004). Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers in surgery and medicine, 34(1):1-4.

Wyss, Pius; Degen Iseli, Andrea Franziska; Caduff, Rosmarie; Hornung, Rene; Haller, Urs; Fehr, Mathias (2003). Fluorescence hysteroscopy using 5-aminolevulinic: a descriptive study. Lasers in surgery and medicine, 33(3):209-212.

Wyss, Pius; Caduff, Rosmarie; Tadir, Yona; Degen Iseli, Andrea Franziska; Wagnières, Georges; Schwarz, Viola; Haller, Urs; Fehr, Mathias (2003). Photodynamic endometrial ablation: morphological study. Lasers in surgery and medicine, 32(4):305-309.

Fehr, Mathias K; Hornung, René; Degen Iseli, Andrea Franziska; Schwarz, Viola A; Fink, Daniel; Haller, Urs; Wyss, Pius (2002). Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers in surgery and medicine, 30(4):273-279.

This list was generated on Sat Jul 22 01:02:09 2017 CEST.